Based on ratings from 3 stock analysts, the Viking Therapeutics Inc stock price is expected to increase by 18.8% in 12 months. This is calculated by using the average 12-month stock price forecast for Viking Therapeutics Inc. The lowest target is $33.00 and the highest is $40.00. Please note analyst price targets are not guaranteed and could be missed completely.
Viking Therapeutics Inc has a total of 3 Wall St Analyst ratings. There are 3 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Viking Therapeutics Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
jay olson Oppenheimer | Buy | $40.0 | maintained | Jan 9, 2024 |
justin zelin BTIG | Buy | $36.0 | maintained | Jan 1, 2024 |
joseph pantginis H.C. Wainwright | Buy | $33.0 | reiterated | Nov 14, 2023 |
naz rahman Maxim Group | Buy | $35.0 | maintained | Oct 26, 2023 |
joon lee Truist Financial | Buy | $32.0 | maintained | Oct 25, 2023 |
thomas smith Leerink Partners | Buy | $28.0 | reiterated | Oct 25, 2023 |
dylan dupuis Roth MKM | Buy | $32.0 | reiterated | Aug 8, 2023 |
annabel samimy Stifel Nicolaus | Buy | $30.0 | maintained | Jun 3, 2023 |
steven seedhouse Raymond James | Buy | $37.0 | maintained | May 17, 2023 |
yale jen Laidlaw | Buy | $35.0 | maintained | May 16, 2023 |
scott henry Roth MKM | Buy | $24.0 | maintained | May 3, 2023 |
matt koranda Roth MKM | Buy | $19.0 | maintained | Mar 29, 2023 |
anthony vendetti Maxim Group | Buy | $25.0 | rated | Mar 28, 2023 |
andy hsieh William Blair | Buy | None | reiterated | Jan 9, 2023 |
matthew luchini BMO Capital | Buy | $15.0 | reiterated | Nov 4, 2021 |
mayank mamtani B.Riley Financial | Hold | None | rated | Aug 6, 2021 |
jason mccarthy Maxim Group | Buy | $14.0 | initiatedcoverage | Jul 29, 2021 |
derek archila Wells Fargo | Buy | $13.0 | reiterated | Apr 28, 2021 |
julian harrison BTIG | Buy | $12.0 | maintained | Apr 28, 2021 |
edward nash Canaccord Genuity | Buy | $28.0 | reiterated | Sep 18, 2018 |
In 2023, VKTX generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that VKTX's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SPLK-USD
$154.42
TEAM-USD
$216.17
$42.33
TXN-USD
$162.4
TXG-USD
$49.11
TWKS-USD
$4.41